New Zealand - English - Medsafe (Medicines Safety Authority)

wyeth (nz) ltd - measles virus, edmonston zagreb 19 strain - solution for injection - active: measles virus, edmonston zagreb 19 strain

New Zealand - English - Medsafe (Medicines Safety Authority)

merck sharp & dohme (new zealand) limited - measles vaccine 1000 tcid50 (edmonston b strain (3 log per dose)); mumps virus, jeryl-lynn strain 19952 tcid50 (b level (4.3 log per dose)); rubella virus, wistar ra27/3 strain 1000 tcid50 ((3 log per dose) ); varicella vaccine 9772 pfu (oka/merck strain (3.99 log per dose));   - injection with diluent - 0.5 ml - active: measles vaccine 1000 tcid50 (edmonston b strain (3 log per dose)) mumps virus, jeryl-lynn strain 19952 tcid50 (b level (4.3 log per dose)) rubella virus, wistar ra27/3 strain 1000 tcid50 ((3 log per dose) ) varicella vaccine 9772 pfu (oka/merck strain (3.99 log per dose))   excipient: dibasic potassium phosphate dibasic sodium phosphate gelatin minimum essential medium eagle medium 199 monosodium glutamate phenolsulfonphthalein potassium chloride sodium bicarbonate sodium chloride sorbitol sucrose urea water for injection - proquad is indicated for vaccination against measles, mumps, rubella, and varicella in individuals 12 months through 12 years of age.

New Zealand - English - Medsafe (Medicines Safety Authority)

seqirus (nz) ltd - measles vaccine 1000 tcid50 - suspension for injection - 1000 tcid50 - active: measles vaccine 1000 tcid50 excipient: alanine arginine hydrochloride asparagine aspartic acid cysteine cysteine hydrochloride monohydrate dextran 70 glutamic acid glycine histidine isoleucine leucine lysine hydrochloride methionine neomycin sulfate phenolsulfonphthalein phenylalanine proline serine sorbitol threonine tryptophan tyrosine urea valine water for injection

Philippines - English - FDA (Food And Drug Administration)

glaxosmithkline philippines, inc. - measles, mumps, rubella (mmr) vaccine (live, attenuated) [see formulation on reverse side] - powder for solution for injection (sc) - after reconstitution, each dose (0.5ml) contains: measles virus (schwarz strain), live attenuated nlt 10 3.0 ccid 50 mumps vir

European Union - English - EMA (European Medicines Agency)

merck sharp & dohme b.v. - virus, live attenuated, measles, virus, live attenuated, mumps, virus, live attenuated, rubella, virus, live attenuated, varicella - chickenpox; rubella; measles; mumps; immunization - vaccines - proquad is indicated for simultaneous vaccination against measles, mumps, rubella and varicella in individuals from 12 months of age. proquad can be administered to individuals from 9 months of age under special circumstances (e.g., to conform with national vaccination schedules, outbreak situations, or travel to a region with high prevalence of measles.,

United States - English - NLM (National Library of Medicine)

csl behring ag - human cytomegalovirus immune globulin (unii: 129l90a25n) (human cytomegalovirus immune globulin - unii:129l90a25n) - human cytomegalovirus immune globulin 50 mg in 1 ml - cytomegalovirus immune globulin intravenous (human) is indicated for the prophylaxis of cytomegalovirus disease associated with transplantation of kidney, lung, liver, pancreas and heart. in transplants of these organs other than kidney from cmv seropositive donors into seronegative recipients, prophylactic cmv-igiv should be considered in combination with ganciclovir. cytogam should not be used in individuals with a history of a prior severe reaction associated with the administration of this or other human immunoglobulin preparations. persons with selective immunoglobulin a deficiency have the potential for developing antibodies to immunoglobulin a and could have anaphylactic reactions to subsequent administration of blood products that contain immunoglobulin a, including cytogam.

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

sm pharmaceuticals sdn. bhd. - measles, live attenuated; rubella, live attenuated -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

sm pharmaceuticals sdn. bhd. - measles, live attenuated; rubella, live attenuated -

Malta - English - Medicines Authority

nm pharma limited 3/4, cantrija complex triq it-targa, il-maghtab naxxar nxr 6613 , malta - powder and solvent for solution for injection - measles virus - schwarz strain 50 % mumps virus jeryl lynn (level b) strain (live, attenuated) 50 % rubella virus - wistar ra27/3 strain 50 % - vaccines

Australia - English - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - measles virus, quantity: 1000 ccid50; rubella virus, quantity: 1000 ccid50; mumps virus, quantity: 25119 ccid50; live varicella vaccine, quantity: 1995 pfu - diluent, not applicable - excipient ingredients: water for injections - priorix-tetra is indicated for active immunisation against measles, mumps, rubella and varicella from 9 months of age.